We are live on ! Find out more
MC

Matisse Capital Portfolio holdings

AUM $234M
1-Year Est. Return 19.72%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+19.72%
3 Year Est. Return
+52.07%
5 Year Est. Return
+45.94%
10 Year Est. Return
+148.24%
AUM
$111M
AUM Growth
-$15M
Cap. Flow
-$17.1M
Cap. Flow %
-15.34%
Top 10 Hldgs %
34.54%
Holding
133
New
12
Increased
28
Reduced
61
Closed
13
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USA icon
51
Liberty All-Star Equity Fund
USA
$1.78B
$590K 0.53%
86,613
-52,117
-38% -$346K
GD icon
52
General Dynamics
GD
$106B
$566K 0.51%
2,763
+1
+0% +$196
BCX icon
53
BlackRock Resources & Commodities Strategy Trust
BCX
$881M
$561K 0.5%
61,835
-35,875
-37% -$322K
LUV icon
54
Southwest Airlines
LUV
$22.7B
$556K 0.5%
8,900
+420
+5% +$24.6K
LMT icon
55
Lockheed Martin
LMT
$134B
$549K 0.49%
1,586
TDF
56
Templeton Dragon Fund
TDF
$267M
$542K 0.49%
27,220
-92,029
-77% -$1.89M
EMD
57
Western Asset Emerging Markets Debt Fund
EMD
$613M
$530K 0.48%
39,467
-26,255
-40% -$354K
IGR
58
CBRE Global Real Estate Income Fund
IGR
$721M
$509K 0.46%
69,663
-50,752
-42% -$380K
BRK.B icon
59
Berkshire Hathaway Class B
BRK.B
$1.1T
$494K 0.44%
2,305
FSD
60
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$481K 0.43%
32,590
-43,126
-57% -$635K
RGT
61
Royce Global Value Trust
RGT
$97.7M
$465K 0.42%
44,249
-29,306
-40% -$309K
ORBC
62
DELISTED
ORBCOMM, Inc.
ORBC
$457K 0.41%
42,040
LRCX icon
63
Lam Research
LRCX
$337B
$451K 0.4%
29,700
+8,100
+38% +$138K
MMM icon
64
3M
MMM
$94.5B
$438K 0.39%
2,488
VPV icon
65
Invesco Pennsylvania Value Municipal Income Trust
VPV
$193M
$429K 0.39%
36,086
-22,809
-39% -$274K
WCG
66
DELISTED
Wellcare Health Plans, Inc.
WCG
$429K 0.39%
1,340
+320
+31% +$90.8K
ISRG icon
67
Intuitive Surgical
ISRG
$131B
$425K 0.38%
2,223
ELV icon
68
Elevance Health
ELV
$83.1B
$420K 0.38%
1,534
+85
+6% +$22.1K
NTC
69
DELISTED
Nuveen Connecticut Quality Municipal Income Fund
NTC
$415K 0.37%
36,526
-23,073
-39% -$269K
MYOV
70
DELISTED
Myovant Sciences Ltd.
MYOV
$405K 0.36%
15,250
SLDB icon
71
Solid Biosciences
SLDB
$772M
$382K 0.34%
+540
New +$339K
AET
72
DELISTED
Aetna Inc
AET
$382K 0.34%
1,883
+463
+33% +$90.5K
MED icon
73
Medifast
MED
$108M
$377K 0.34%
1,700
-50
-3% -$10.1K
GOOGL icon
74
Alphabet (Google) Class A
GOOGL
$4.08T
$375K 0.34%
+6,220
New +$377K
BQH
75
DELISTED
BlackRock New York Municipal Bond Trust
BQH
$369K 0.33%
28,663
+6,648
+30% +$86.5K

Similar funds

Matisse Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Matisse Capital held 133 positions worth $111M, down 12% from $126M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Matisse Capital withdrew a net $17.1M in Q3 2018, closing 13 positions and reducing 61 holdings. Its most notable exit was Sage Therapeutics, an estimated $391K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, up from 3.6% a quarter earlier, followed by Real Estate and Technology.

Against the trend, Matisse Capital opened a new position in Nuveen Arizona Quality Municipal Income Fund worth $1.25M.

  • Matisse Capital's largest Q3 2018 buy was Nuveen Arizona Quality Municipal Income Fund: 107,024 shares worth $1.25M.
  • Matisse Capital added most to BlackRock New York Municipal Income Trust II in Q3 2018, an estimated $643K increase.
  • Matisse Capital's biggest Q3 2018 reduction was Central Securities Corp, cutting an estimated $3.8M.
  • Matisse Capital fully exited Sage Therapeutics in Q3 2018, selling an estimated $391K.
  • Matisse Capital's ten largest holdings make up 35% of its $111M portfolio in Q3 2018.
  • Matisse Capital opened 12 new positions and closed 13 in Q3 2018.
  • Matisse Capital's portfolio value fell 12% quarter-over-quarter to $111M.

Based on Matisse Capital's 13F filing for Q3 2018, filed 30 Oct 2018.